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Pathological changes associated with the development of brain tumor were investigated by Fourier transform infrared microspectroscopy (FT-
IRM) with high spatial resolution. Using multivariate statistical analysis and imaging, all normal brain structures were discriminated from tumor
and surrounding tumor tissues. These structural changes were mainly related to qualitative and quantitative changes in lipids (tumors contain little
fat) and were correlated to the degree of myelination, an important factor in several neurodegenerative disorders. Lipid concentration and
composition may thus be used as spectroscopic markers to discriminate between healthy and tumor tissues. Additionally, we have identified one
peculiar structure all around the tumor. This structure could be attributed to infiltrative events, such as peritumoral oedema observed during tumor
development. Our results highlight the ability of FT-IRM to identify the molecular origin that gave rise to the specific changes between healthy
and diseased states. Comparison between pseudo-FT-IRM maps and histological examinations (Luxol fast blue, Luxol fast blue-cresyl violet
staining) showed the complementarities of both techniques for early detection of tissue abnormalities.
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Malignant cerebral tumors account for 1 to 2% of all cancers,
and among those, 30% are gliomas [1]. Gliomas are tumors
which infiltrate the cerebral parenchyma gradually, increasing
intracranial pressure and causing neuronal loss. In spite of a
growing therapeutic arsenal, treatment of glioblastomas remains
difficult, and median patient survival has not changed over the
last 20 years. In addition to surgery and radiotherapy,
chemotherapy protocols are often set up, allowing, in certain
cases, an increase in the lifespan of patients [2]. This result,
although modest, justifies the continuation of the investigations
aiming at the development of new powerful techniques to better
understand the molecular pathogenesis of glioma. As such,
better knowledge of the dynamics of tumor invasion and
neovascularisation appears to be crucial for the development of
new therapeutic approaches.
Fourier transform infrared microspectroscopy (FT-IRM) is a
technique sensitive to molecular composition and molecular
conformational changes associated to tumor development not
easily detectable by morphological methods. Previous studies
have demonstrated the potential of this technique in discrim-
inating diseased from healthy tissue [3,4], apoptotic and
necrotic tissues [5,6], sensitive and multi-resistant cells [7],
and the effect of anti-cancer chemotherapy [8,9].
In this study, FT-IRM was used to investigate the molecular
changes associated with the development of brain glioma.
Multivariate statistical analysis and imaging was applied to
discriminate normal brain structures from tumor and surrounding
tumor tissues. The experimental C6 Rat glioma model was chosen
because of its similar morphology to glioblastoma multiform and
its rapid proliferation rate. Data obtained with FT-IRM, were
correlated with histopathological examinations to understand the
molecular changes associated with tissue alteration.2. Materials and methods
2.1. Animal model
Male Wistar rats, weighing between 260 and 300 g, (Elevage Dépré, France)
were individually housed in a controlled environment (20±2 °C; 65±15%
relative humidity) and maintained under a 12:12 h light:dark cycle. They had
access to food (U.A.R., France) and tap water ad libitum. They were randomly
allocated to one of two study groups: Control and C6 tumor. All animal
procedures adhered to the “Principles of laboratory animal care” (NIH
publication #85-23, revised 1985) and the European Community guidelines
for the use of experimental animals.
2.2. Glioma cell lines
The C6 glioma cell line was initially produced by means of weekly injections
of N-methylnitrosourea [10]. C6 cells were maintained in NUT.MIX.F-12
(HAM)minimum essential medium containing 10% fetal calf serum (GibcoBRL,
France). They were grown to confluence in a humidified atmosphere of 5% CO2
at 37 °C. Exponential growth cultures were harvested with a solution of 0.05%
trypsin and 0.02% EDTA, and resuspended in NUT.MIX.F-12 (HAM) medium.
Cells were washed three times in NUT.MIX.F-12 (HAM) medium and viable
cells counted by a trypan blue dye exclusion method. Finally, cells were
suspended in NUT.MIX.F-12 (HAM) minimum essential medium to a final
concentration of 5.106 cells per 10 μl for intracerebral inoculation.2.3. Intracerebral inoculation
Rats were anesthetised by i.p. injection of 10 mg/kg xylazine (Bayer,
Germany) and 100 mg/kg ketamine (Parke-Davis, France). Their head was
mounted into a stereotactic head holder (Stoelting model 51600, Phymep,
France) in a flat-skull position, the scalp cleaned with 70% ethanol, and the skull
exposed by a midline incision. A small burr hole was drilled into the right side at
a location defined by the following stereotactic coordinates: 1 mm anterior to the
bregma; 3 mm lateral from the midline. Ten microliters of the tumor cell
suspension were then injected with a syringe over 2 min at a depth of 4 mm from
the skull surface, coordinates corresponding to the caudate putamen (CP).
2.4. Sample preparation
Twenty days after tumor cell injection, control and tumor bearing rats were
sacrificed and their brains removed. Macroscopic sections (2 mm) wide were
immediately performed and frozen in methyl-butane cooled with liquid nitrogen.
For each section, 8 μm thick samples were sectioned with a cryostat and placed
on Zinc Selenide (ZnSe) transparent infrared windows. Three adjacent tissue
sections were routinely stained with hematoxylin and eosin (H&E), Luxol fast
blue (LFB), and LFB counterstained with cresyl violet (LFB-CV) for
microscopic examination. The histopathological H&E staining was used to
determine the zone of interest for FT-IRM measurement.
2.5. Staining of myelinated fibers with Luxol Fast Blue
Briefly, slide-mounted 8 μm cryosections were fixed in formaldehyde for
1 h, rinsed in distilled water, and transferred through 95% ethanol to a 0.1%
solution of LFB (MBS, Sigma, France) in 95% ethanol and 0.05% acetic acid.
After staining overnight at 58 °C, sections were washed with distilled water, and
subsequently with PBS, differentiated in 0.05% aqueous lithium carbonate
followed by 70% ethanol, and washed in distilled water before standard
mounting, dehydrating, and cover slipping.
2.6. Counterstaining with cresyl violet
Slide-mounted sections were rinsed with distilled water and incubated for
10 min in a solution of cresyl violet (Sigma, France) in acetate buffer, dehy-
drated through a graded series of ethanol, and coverslipped. A color video
camera (DC300, Canon, France) attached to a microscope (DMRB, Leica,
Germany) captured histological sections as digital images that were further
enhanced on a computer using IM50 (version 1.20, France).
2.7. FT-IRM spectra
FT-IRM spectra were recorded on a Spectrum Spotlight 300 infrared
imaging spectrometer (Perkin-Elmer instrument, UK) coupled to an IR
microscope with a liquid nitrogen cooled 16×1 Mercury–Cadmium–Telluride
(MCT) array detector. The array detection mode allows the generation of
molecular specific images over a total area of 1.64 cm2. Pixel resolution used in
this study was 25 μm, thus allowing images to be collected more rapidly than the
serial collection point detector. The array detector provides a useful spectral
range of 720 to 4000 cm−1. The microscope was equipped with a movable,
software controlled, x,y stage directly linked to the spectrometer's interferom-
eter and synchronised to move every time the interferometer changed direction
up to five times per second. The stage position was highly reproducible (CV:
0.001%) and much easier to control than the moving mirror position in a step
scan spectrometer. Spectra were recorded with a final resolution of 4 cm−1, with
two accumulations for each point. Data acquisition was carried out by means of
the Spotlight software package (V. 1.1.0, PerkinElmer, Paris).
2.8. Data pre-treatment
To allow meaningful comparisons, all FT-IRM data were uniformly
pretreated. After atmospheric correction, all spectra (in the regions 900–
1800 cm−1) were converted to their first derivative using a seven point
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The resulting spectra were then scaled using a Standard Normal Variate (SNV)
procedure [11]. In this transformation, every spectrum is mean centered (so that
the average of the spectral intensities in all wavenumber channels is zero) and
scaled to have a standard deviation of one.
2.9. Data treatment
After appropriate pre-treatment, a multivariate statistical analysis was
performed to extract the desired clinically relevant data from FT-IRM spectra.
Data from healthy and cancer brain tissues were placed in a similar matrix and
processed by Principal Component Analysis (PCA) and K-Means (KM)
clustering analysis to build maps with similar color scales. The aim of this data
processing was to find common and discriminating structures between healthy
and tumor tissues by comparing their infrared maps.
PCAwas performed on the data to remove redundancies at different locations
in the spectra by finding the independent sources of variation in all spectra, and to
reduce the number of variables describing the data set. Maps based on principal
component scores were then used to find the independent sources associated with
healthy and cancer brain tissues. K-means clustering was performed on these
principal component scores instead of on raw data to handle the large amount of
data obtained during FT-IRM mapping experiments. KM clustering is a non-
hierarchical clustering method, which gives a ‘‘hard'’ (crisp) class membership
for each spectrum, (i.e., the class membership of an individual spectrum can only
take the values 0 or 1) [12–14]. In the present study, we used a setting of 100 for
the maximal number of iterations and up to 10 for the number of clusters.
Pseudo-color maps based on cluster analysis were then created by assigning
a color to each spectral cluster. Each spectrum of a mapping experiment had a
unique spatial x,y position in the map, and false-color images could be generated
by specifically plotting colored pixels as a function of their spatial coordinates.
Spectra of different clusters ideally exhibit different spectral signatures. The
cluster components were calculated by averaging the clusters and used for the
interpretation of the chemical or biochemical differences between clusters [15].
The processing analysis on FT-IRM data was performed with Matlab
(Version 5.3, MathWorks, Inc., Matick, USA).3. Results
Multivariate statistical analysis was performed on a data set
containing all FT-IRM measurements obtained from healthy
and tumor brain tissues. Seven clusters describing both healthy
and cancer features, and one cluster corresponding to ZnSe,
were extracted and the pseudo FT-IRM maps were constructed
with the same color scale.
Fig. 1C displays an infrared map obtained from healthy
brain tissue. In this pseudo-color map, 5 clusters were
sufficient for describing all normal brain features. FT-IRM
images allow clear identification of the anatomical structures
of the rat brain. Gray matter (e.g., cortical cortex), which
naturally has a much higher content of water and proteins, was
encoded by four colors (yellow, red, brown and cyan). Grey
cluster in the image seems to correlate with white matter tissue,
the corpus callosum (CC), and commissura anterior (CA).
Cyan-colored areas are typical for one structure of cortex and
around the caudate putamen (CP) which are heavily myelin-
ated and consist largely of lipids. However, other colors,
associated with cortex, seem to correspond to the differing lipid
content.
An infrared spectrum of brain tissue is a fingerprint that
reflects its composition. To illustrate this molecular specificity
for brain features, Fig. 2 shows class average of the normal
tissue class. These spectra are dominated by two absorbancebands at 1656 and 1546 cm−1 known as the amide I and II,
respectively. Amide I arises from C_O hydrogen bonded
stretching vibrations and amide II from C–N stretching and
CNH bending vibrations. The weaker amino acid side chain
from peptides and proteins at 1452 cm−1 was associated with
the asymmetric and symmetric CH3 bending vibrations. The
band at 1740 cm−1 arises from the stretching mode of C_O
groups of lipids. The strongest bands, at 1236 cm−1 and
1084 cm−1 are due to the asymmetric and symmetric phosphate
stretching mode PO2
−, respectively. The relatively weak band at
1172 cm−1, in the healthy tissue is due to stretching mode of
C–O groups of proteins [7]. The bands located at 1466 cm−1
and 1382 cm−1 are due to CH2 and CH3 banding of cholesterol
and/or phospholipids [16] strongly representing in component
8 which is characteristic of CC. Moreover, all normal brain
structures were characterised by a variation in the peak position
and intensities of all these previous bands. In fact, lipids
content decreased around CC and disappeared in the cortex.
Comparison between pseudo-color maps and the histopa-
thology images (Fig. 1A) shows that the FT-IRM image
provides more information on the cortex and around CP than
standard histopathology. In fact, four layers were identified
from the cortex, whereas, H&E staining did not allowed to
discriminate between the layers in the cortex. LFB staining
was then used to visualise myelin distribution into brain
tissues and to map particular sections within the cortex. In
stained preparations, myelin is intensely blue, so that white
matter is well differentiated from gray matter (Fig. 3A). In
fact, large fiber tracts like CC, CA and some bundles in CP
can be easily recognised. In Fig. 3A, LFB staining shows a
gradation color density between brain structures. CC and CA
present an important lipid content due to high myelin level in
these structures involved in communication within and
between hemispheres. However, even with higher magnifica-
tion it was very difficult to distinguish between all cortex
layers because this staining is mainly restricted to fibers. Thus,
the individual cell type cannot be recognised within the tissue.
This LFB staining was then combined with cresyl violet
coloration to stain not only rough endoplasmic reticulum
(Nissl substance) but chromatin and nucleoli as well. This
coloration was used in our study to visualise all the different
cell types present in the cortex (Fig. 3B). With this coloration
six different layers were then identified in the cortex instead of
four layers in the FT-IRM map. On the other hand, when
multivariate statistical analysis was applied only on FT-IRM
data measured from normal brain tissue we were able to
distinguish between five cortex layers. This pseudo-color map
was correlated with that obtained with LFB-CV staining (Fig.
3B). The outermost molecular layer (I) containing non-specific
fibers, corresponds to the yellow cluster. The external granular
layer (II) is a rather dense layer composed of small cells. The
external pyramidal layer (III) contains pyramidal cells,
frequently in row formation. The internal granular layer (IV)
is usually a thin layer with cells similar to those in the external
granular layer. These layers II, III and IV were not clearly
discriminated and seem to correspond to the red and blue
clusters. The ganglionic layer (V) contains, in most areas,
Fig. 1. Photomicrography of HE stained healthy brain tissue (A) and glioma tissue (B) sections. In figure (A), particular structures can be recognised such as CC that
appears as a “V” shape with the genu (apex) pointing medially, and CA. In figure B, the more intensely stained area, marked “T” represents tumor zone. The pseudo-
color FTIR maps (C) and (D) were obtained from the measured areas marked with a black frame on the adjacent unstained healthy (A) and glioma (B) tissues,
respectively. The size of the measured area was 5.5×7.6 mm2 for both tissues. 60×80 spectra (expressed in pixels) were recorded on these areas of interest. Pseudo-
color FTIR maps were constructed on 8-means clusters. Each cluster (consisting of similar spectra) was assigned to one brain feature. Blue: denotes areas in the scan
where no tissue was present; yellow, red, brown and cyan: Cortex areas; grey: CC and CA areas; green: tumor tissue area; pink: infiltrative zone.
895N. Amharref et al. / Biochimica et Biophysica Acta 1758 (2006) 892–899pyramidal cells that were fewer in number but larger in size
than those in the external pyramidal layer (brown). The
fusiform layer (VI) consists of irregular fusiform cells whose
axons enter the adjacent white matter known as the CC (cyan)
[17].
Since tissue composition is altered by tumor invasion,
infrared spectra of malignant glioma differ from that of normal
tissue. We have investigated the molecular changes associated
with malignant rat brain tumor. Fig. 1D displays an infrared
map obtained from tumor brain tissue and constructed on 7/
8 clusters. This pseudo-color map shows some common
structures with normal tissue such as CC, and three layers
associated with cortex (cyan, red and brown). Other structures
were restricted to tumor tissue (component 6 and 8). The
component 8 was located around the tumor and could be
attributed to the oedema. Indeed, brain tumors contain tumor
vessels that may have different structural properties favouring
the formation of oedema within and around the tumor. Ide et al.
found a correlation between peritumoral brain oedema and
cortical destruction by the tumor [18]. Fig. 1D shows also therecoil of CC by tumor development. The difference spectrum
between normal and tumor structures were prominent by lipid
features meaning that the contribution of fat in the tumor tissue
decreased. Our data showed molecular changes between
healthy and tumor tissue (Fig. 2A). In fact, the relatively
weak band at 1172 cm−1, in the healthy tissue, due to
stretching mode of C–O groups of proteins, decreased and
shifted to 1190 cm−1 in the tumor and surrounding tumor
spectra. The weaker amino acid side chain from peptides and
proteins at 1452 and 1392 cm−1 are associated with the
asymmetric and symmetric CH3 bending vibrations. In the
malignant brain, i) the lipid/proteins ratio (1466/1452 cm−1)
decreased, ii) the band at 1740 cm−1 become weak and even
disappeared when compared to the corresponding bands in
healthy. The variations of the spectral characteristics of the FT-
IRM spectra between the normal and malignant tissues
provided a basis for clinical application.
The study of the frequency region 1000–1350 cm−1 revealed
significant differences in the infrared spectra between healthy
and tumor tissues. The bands at 1070 cm−1 and 1084 cm−1 are
Fig. 2. Representative cluster-averaged IR spectra collected from healthy brain and glioma tissue sections in the spectral region (A) 750 cm−1 to 1900 cm−1, and (B)
2500 cm−1 to 3800 cm−1. Spectra are shown with the same color scale than in pseudo color maps C and D.
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mode PO2
−, respectively. In all case, when compared with
healthy tissues, the malignant tissues displayed a decreased
intensity of the asymmetric PO2
− (1236 cm−1) band and of the
C–C stretching (1070 cm−1) band, an increased intensity of the
symmetric PO2
− (1084 cm−1) band, and changes in the shape of
these bands (become large).
The lipids spectra contain a large proportion of methyl,
methylene and carbonyl bands in the region 2600–3700 cm−1.
Fig. 2B displays the infrared spectra of healthy and malignant
glioma tissues in this region. The bands at 2852 cm−1 and
2922 cm−1 were due to the symmetric CH2 stretching mode of
the membrane lipid. The band at 2954 cm−1 is due to
asymmetric CH3 stretching mode of the methyl group. The
asymmetric CH3 stretching of lipids and proteins contribute to
the intensity of the band at 2954 cm−1. The bands were assigned
to CH2, CH3 stretching vibrations of cholesterol and phospho-
lipids. In the malignant tissues, the intensity of the CH2 band
CH3 bands decreased compared to the corresponding bands in
healthy tissue.
LFB and LFB-CV staining were used to visualise myelin
distribution into tumor brain tissues (data not shown). Some
normal features such as CC, CA, and CP were recognised but
these colorations failed to reveal the tumoral and peritumoral
part of the tissue.
4. Discussion
The objective of this study was to determine tissue
modifications between tumoral and healthy brain tissue and to
better identify the nature of the surrounding tumor tissue by FT-
IRM. FT-IRM images presented here allow clear identification
of anatomical structures of the healthy rat brain (CC, CA, andcortex), changes associated to tumor and the surrounding tumor.
Our results demonstrate the potential of this technique in
successfully discriminating between healthy, tumoral, and
surrounding tumor tissues.
In fact, the grey structure in the image seems to correlate with
white matter tissue (e.g., which is more myelinated and consist
largely of lipids, i.e., fats). The other colors seem to correspond
to the differing contents of fat in brain tissue. The gray matter of
the brain (e.g., Cortex, CP), which naturally has a much higher
content of water and proteins, was described with 3 components
with different lipid content. This fat distribution in brain tissue
was correlated to the degree of myelination.
As the image contrast is based on the vibrational signature of
the tissue components, FT-IRM imaging does not require the
use of dyes, tags or stains. On the other hand, histopathological
diagnosis depends on visualisation of the sample morphology
by staining technique. In spectral diagnosis, objective intrinsic
structural and morphological information, on measured area,
were simultaneously collected. By correlating FT-IRM spectral
maps with histopathology (H&E, LFB, and LFB-CV) of the
adjacent tissue sections, we highlighted the potential of FT-IRM
to identify the morphologic origin that gave rise to the specific
spectral features found in this study. In fact, with standard
staining (H&E), we were not able to discriminate between the
different cortex layers. On the other hand, FT-IRM pseudo-color
maps were clearly similar to LFB-CV staining for visualising
myelin distribution in healthy brain tissues (white and gray
matters). Yet, this staining technique failed to visualise the
tumor and peritumoral part of the tissue.
This spectroscopic study pointed out different cortex layers
which are not easily detectable by morphological methods
alone. The cortex consists of a thin layer of gray substance
which covers the two hemispheres and whose thickness varies
Fig. 3. Photomicrography of a brain tissue section at low (A) and high (B) magnification, respectively. (A) is stained with LFB; in this image CC, CA and CP
appears more lightly stained. (B), a small area of (A) marked with a red frame, stained with LFB-CV, pointing out the cortical layers of the rat cortex. Pseudo-
color FTIR map (C) based on K-means cluster analysis applied only on FTIR data measured from normal brain tissue. The complementarity between structural
(C) and morphological (B) information is represented by a dotted line. Yellow: Layer I of the cortex. Red and blue: Layers II, III and IV; brown: Layer V, cyan:
Layer VI and grey: corpus callosum.
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organisation, one distinguishes 6 layers numbered from I to VI
from top to bottom [19]. In the spectral image, the cortex is
separated in four different regions. One of the most
pronounced difference separating those regions is the compo-
sition in myelin. Indeed, layer VI, adjacent to the CC clearly
identified in the spectral map (cyan) is principally composed
on elongated neuronal myelinated fibers that lie parallel to the
CC neurons. This layer appeared particularly rich in myelin
sheath. A second region (brown) is correlated with the layer V
or pyramidal layer. This internal layer primarily contains
pyramidal neurons whose apical dendrites are projected either
in the molecular layer (layer I) or in the internal granular layer
(layer IV). A third region corresponds to the layer II, III and IV
in which myelinated fibers are less prominent. Finally the last
region (yellow), corresponding to the molecular external layer(layer I) consisting of glial cells and nervous fibers with ways
parallel to the cortical surface.
During tumor development, tissue composition and con-
centration of lipids decreased. This loss of lipids, correlated
with demyelination, observed in different disorders, could be
used as a spectroscopic marker. These results are in agreement
with those obtained in brain pathologies [20], whereas,
observations in other tumor types revealed an increase of
lipids in tumor tissue [21]. Kraft et al. have investigated the
lipid content of the white matter of human brain tissue using
near infrared Raman spectroscopy [22]. They reported that the
brain lipids can be divided into three principal classes: neutral
lipids, phospholipids and sphingolipids. Increased levels of
cholesterol esters (particularly cholesterol oleate and choles-
terol linoleate) in glioma tissue have been reported before [23–
25]. In these studies and in ours, necrotic and vital tumor
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specific information regarding the biochemical composition of
these distinct tumor regions was obtained. Previous studies on
brain tumors using proton magnetic resonance spectroscopy
[26–28,] also provided evidence of mobile lipid resonances
(resonances arising from fatty acyl chains of lipids), possibly
caused by cell proliferation arrest and necrosis. These findings
were confirmed by other magnetic resonance spectroscopy
studies in which the morphologic and biochemical features
were compared [29–31].
We were also interested to surrounding tumor tissue. Indeed,
in our FT-IRM data, we have detected one different structure
(component 9) around the tumor. This structure could be
attributed to the peritumoral oedema observed during glioma
development. In fact, brain tumors contain new vessels that may
have different structural properties favouring the formation of
oedema within and around the tumor [18]. This oedema
associated with brain tumor is due to an increase in the
permeability of the blood–brain barrier and aggravate the mass
effect of tumors. The diagnosis of peritumoral brain oedema is
assisted by the use of imaging techniques such as computed
tomography, magnetic resonance imaging, and spectroscopy.
As tumors enlarge, they produce angiogenic factors that
promote the emergence of new capillaries to supply the growing
tumors. Newly formed capillaries are fenestrated and present
less tight junctions, leading to the development of a peritumoral
oedema. Moreover, C6 glioma cells in culture demonstrated
secretion of diffusible factor that increase capillary permeability
[32]. On the other hand, the surrounding tumor tissue is
associated to the infiltrative zone. Indeed, glioblastoma
typically grow through the surrounding brain parenchyma,
intermingling with normal and reactive cells. Ide et al. found a
correlation between peritumoral brain oedema and brain
parenchyma destruction by the tumor [18]. In fact, this
alteration corresponds to the myelin degradation in order to
allow the infiltration of tumor cells. Myelin is responsible for
the inhibition of cellular migration, and thus, the invasive
process requires degradation of different myelin components
[33]. Invasion is partially due to proteases that penetrate the
surrounding tissue, induce vascular remodelling and destroy
extracellular matrix [34].
This study demonstrates the potential of FT-IRM in
successfully discriminating between normal brain structures,
tumoral, and surrounding tumoral tissues. The structural
changes were mainly related to qualitative and quantitative
changes of lipids and will be used as spectroscopic markers
for this pathology. In our FT-IRM data, the structure detected
around the tumor could be attributed to the peritumoral
oedema observed during glioma development. FT-IRM, with
high spatially resolved morphological and biochemical
information could be used as a diagnostic tool, complemen-
tary to histopathology to understand the molecular changes
associated with tissue alteration. Future work will allow the
quantification of biochemical changes (lipid and proteins)
between healthy and tumor tissues by fitting the measured
spectra with linear combination of the spectra of major pure
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